JFLLIFE — JFL Life Sciences Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- IN₹650.01m
- IN₹818.15m
- IN₹327.75m
Annual cashflow statement for JFL Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Net Income/Starting Line | 4.23 | 4.97 | 7.47 |
Depreciation | |||
Non-Cash Items | 6.47 | 11 | 11.4 |
Other Non-Cash Items | |||
Changes in Working Capital | -42.3 | 13.8 | -80.2 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -30 | 32.1 | -58.7 |
Capital Expenditures | -6.11 | -27.8 | -17.2 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 0.018 | 0.223 | 0.791 |
Other Investing Cash Flow | |||
Cash from Investing Activities | -6.09 | -27.6 | -16.4 |
Financing Cash Flow Items | -6.28 | -11 | -12 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 36.1 | -1.89 | 72.5 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -0.012 | 2.68 | -2.61 |